On the left is the proportion of individuals positive in each diagnostic state prior to MDA occurring: pink—PCR positive only, purple—PCR and TF positive, blue—TF positive only, each x axis label indicates what the initial endemic prevalence was in the community prior to intervention. On the right is the proportion of individuals in each diagnostic state following 3 annual rounds of MDA for each initial level of endemic prevalence (as shown on the x label), again pink—PCR positive only, purple—PCR and TF positive, blue—TF positive only. At high levels of initial endemic prevalence we see the highest proportion of individuals test both PCR and TF positive as a result of rapid rates of re-infection within the community, while at lower levels ...
<p>Results of 43-point prevalence surveys undertaken during the intervention period (January–Decembe...
<p>a, the percentage of subjects remained with CD4+ T cell counts >200 cells/µl during the follow-up...
<p>A, the positive detection rates (PDRs) according to patient total, sex, age and its subgroups; B,...
a) prevalence of infection and disease prevalence change during re-emergence within the community, p...
PCR and TF prevalence post-MDA for different initial endemicities (black dots), and for 10,000 diffe...
a) prevalence of infection and disease prevalence change during an intervention within the community...
Total proportion of patients with MDR-TB after initial attempt at diagnosis and treatment, based on ...
<p>Model outputs and observed infection data are shown for all the five PNG study villages. The obse...
<p>A, the total number of samples and the PDR patterns in each month of each year; B, the prevalence...
<p>Data shown are the number of subjects with positive tests and the number of Mf-positive subjects ...
<p>Incidence events for each test were defined as positive tests in people who had tested negative i...
Proportion of patients with acquired MDR-TB after initial attempt at diagnosis and treatment, based ...
<p>A. Proportion of patients with new or increased symptoms (NOIS) at baseline or incomplete respons...
<p>Here, ‘baseline’ implies no Xpert, and current levels of DST amongst current MDR risk-groups (sme...
Prevalence of MDR-TB in population after initial attempt at diagnosis and treatment, per 100 000 ind...
<p>Results of 43-point prevalence surveys undertaken during the intervention period (January–Decembe...
<p>a, the percentage of subjects remained with CD4+ T cell counts >200 cells/µl during the follow-up...
<p>A, the positive detection rates (PDRs) according to patient total, sex, age and its subgroups; B,...
a) prevalence of infection and disease prevalence change during re-emergence within the community, p...
PCR and TF prevalence post-MDA for different initial endemicities (black dots), and for 10,000 diffe...
a) prevalence of infection and disease prevalence change during an intervention within the community...
Total proportion of patients with MDR-TB after initial attempt at diagnosis and treatment, based on ...
<p>Model outputs and observed infection data are shown for all the five PNG study villages. The obse...
<p>A, the total number of samples and the PDR patterns in each month of each year; B, the prevalence...
<p>Data shown are the number of subjects with positive tests and the number of Mf-positive subjects ...
<p>Incidence events for each test were defined as positive tests in people who had tested negative i...
Proportion of patients with acquired MDR-TB after initial attempt at diagnosis and treatment, based ...
<p>A. Proportion of patients with new or increased symptoms (NOIS) at baseline or incomplete respons...
<p>Here, ‘baseline’ implies no Xpert, and current levels of DST amongst current MDR risk-groups (sme...
Prevalence of MDR-TB in population after initial attempt at diagnosis and treatment, per 100 000 ind...
<p>Results of 43-point prevalence surveys undertaken during the intervention period (January–Decembe...
<p>a, the percentage of subjects remained with CD4+ T cell counts >200 cells/µl during the follow-up...
<p>A, the positive detection rates (PDRs) according to patient total, sex, age and its subgroups; B,...